Patient Home Monitoring retains Equicom for strategic investor relations

NewsGuard 100/100 Score

Patient Home Monitoring (PHM) (TSX: PHM), a company focused on in-home cardiology healthcare services, today announced that it has retained The Equicom Group Inc. ("Equicom") to provide the Company with strategic investor relations.

"PHM is a very fast growing company." said Michael Dalsin, Chairman of Patient Home Monitoring, "It is crucial to ensure the capital markets are up to date on the progress the company is making as it matures. Equicom has a strong track record of supporting fast growing publically-listed companies and we are happy to have them supporting PHM."

Equicom provides strategic communications services to approximately 100 public companies across a diverse range of industries. Under the terms of the agreement, Patient Home Monitoring (PHM) will pay Equicom a monthly fee of $2,500 for select communication services. The initial contract term is 12 months and has been in effect since April 1, 2010 - prior to PHM's public listing.

Neither Equicom nor any of its principals have an ownership interest, directly or indirectly, in PHM or its securities, nor has the Company granted Equicom or its principals any rights to acquire any such interests. Equicom is a wholly-owned subsidiary of TMX Group Inc.

Source:

PHM PATIENT HOME MONITORING

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mapping the heart's cellular blueprint: New insights into cardiac structure and disease repair